genedrive plc announces that initial orders of the Genedrive® MT-RNR1 products have been received from France, Austria, Greece, Saudi Arabia, Turkey and the Netherlands. This follows the Company recently confirming that commercial distribution agreements for the genedrive test for antibiotic induced hearing loss ("AIHL") in a number of countries had been signed. The initial orders will support genedrive's international distribution partners in promotion and in-country evaluation activities in their respective countries, to provide more extensive access to this life-changing test.